ロード中...
LDL Cholesterol, Statins And PCSK 9 Inhibitors
Reduction of low density lipoprotein cholesterol (LDLc) is of vital importance for the prevention of atherosclerotic cardiovascular disease (ASCVD). Statin is the most effective therapy today to lower LDLc by inhibiting HMG-CoA-reductase. However despite intensive statin therapy, there remains a res...
保存先:
| 出版年: | Indian Heart J |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4593843/ https://ncbi.nlm.nih.gov/pubmed/26432726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2015.05.020 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|